Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists nationwide audit

Harshal Deshmukh; Emma G Wilmot; Pratik Choudhary; Parth Narendran; Najeeb Shah; Dennis Barnes; Shafie Kamruddin; Rumaisa Banatwalla; Peter Christian; Simon Saunders; Alistair Lumb; Roselle Herring; Jane Patmore; Chris Walton; Robert E J Ryder; Thozhukat Sathyapalan

doi:10.2337/dc21-1181

Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists nationwide audit

Harshal Deshmukh, Emma G Wilmot, Pratik Choudhary, Parth Narendran, Najeeb Shah, Dennis Barnes, Shafie Kamruddin, Rumaisa Banatwalla, Peter Christian, Simon Saunders, Alistair Lumb, Roselle Herring, Jane Patmore, Chris Walton, Robert E J Ryder, Thozhukat Sathyapalan

Immunology and Immunotherapy

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	e190-e191
Number of pages	2
Journal	Diabetes Care
Volume	44
Issue number	11
Early online date	15 Sept 2021
DOIs	https://doi.org/10.2337/dc21-1181
Publication status	Published - Nov 2021

Bibliographical note

Funding Information:
Acknowledgments. The authors thank all the clinicians and support staff who participated in the nationwide study, listed at https://abcd.care/ Resource/ABCD-Freestyle-Libre-Audit-Contributors. Funding. The ABCD nationwide FSL audit is supported by a grant from Abbott Laboratories. H.D. is funded by a National Institute for Health Research clinical lectureship. Duality of Interest. E.G.W. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. is also an honorary member of the Medical Advisory Panel on Diabetes to the Secretary of State for Transport. C.W. has a spouse/partner serving on the advisory panel for Celgene and on the speakers bureau for LEO Pharma and Novar-tis. R.E.J.R. serves on the advisory panel for Novo Nordisk A/S and on the speakers bureau for BioQuest. T.S. is on the speakers bureau for the Novo Nordisk Foundation and reports a relationship with Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi. The FSL audit was independently initiated and performed by ABCD, and the authors remain independent in the analysis and preparation of this report. No other potential conflicts of interest relevant to this article were reported. Author Contributions. H.D., E.G.W., C.W., R.E.J.R., and T.S. conceived the presented idea. H.D., E.G.W., C.W., R.E.J.R., and T.S. contributed to the data analysis. H.D. wrote the first draft of the manuscript. All of the authors contributed to the writing of the manuscript and made extensive comments, criticisms, and changes to the final draft of the paper. All of the authors saw the final version of the manuscript. H.D. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

ASJC Scopus subject areas

Advanced and Specialised Nursing
Internal Medicine
Endocrinology, Diabetes and Metabolism

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2337/dc21-1181

https://hull-repository.worktribe.com/output/3844383

Cite this

Deshmukh, H., Wilmot, E. G., Choudhary, P., Narendran, P., Shah, N., Barnes, D., Kamruddin, S., Banatwalla, R., Christian, P., Saunders, S., Lumb, A., Herring, R., Patmore, J., Walton, C., Ryder, R. E. J., & Sathyapalan, T. (2021). Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists nationwide audit. Diabetes Care, 44(11), e190-e191. https://doi.org/10.2337/dc21-1181

@article{3415e44ce9234f47abf5ddba573d7df1,

title = "Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists nationwide audit",

author = "Harshal Deshmukh and Wilmot, {Emma G} and Pratik Choudhary and Parth Narendran and Najeeb Shah and Dennis Barnes and Shafie Kamruddin and Rumaisa Banatwalla and Peter Christian and Simon Saunders and Alistair Lumb and Roselle Herring and Jane Patmore and Chris Walton and Ryder, {Robert E J} and Thozhukat Sathyapalan",

note = "Funding Information: Acknowledgments. The authors thank all the clinicians and support staff who participated in the nationwide study, listed at https://abcd.care/ Resource/ABCD-Freestyle-Libre-Audit-Contributors. Funding. The ABCD nationwide FSL audit is supported by a grant from Abbott Laboratories. H.D. is funded by a National Institute for Health Research clinical lectureship. Duality of Interest. E.G.W. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. is also an honorary member of the Medical Advisory Panel on Diabetes to the Secretary of State for Transport. C.W. has a spouse/partner serving on the advisory panel for Celgene and on the speakers bureau for LEO Pharma and Novar-tis. R.E.J.R. serves on the advisory panel for Novo Nordisk A/S and on the speakers bureau for BioQuest. T.S. is on the speakers bureau for the Novo Nordisk Foundation and reports a relationship with Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi. The FSL audit was independently initiated and performed by ABCD, and the authors remain independent in the analysis and preparation of this report. No other potential conflicts of interest relevant to this article were reported. Author Contributions. H.D., E.G.W., C.W., R.E.J.R., and T.S. conceived the presented idea. H.D., E.G.W., C.W., R.E.J.R., and T.S. contributed to the data analysis. H.D. wrote the first draft of the manuscript. All of the authors contributed to the writing of the manuscript and made extensive comments, criticisms, and changes to the final draft of the paper. All of the authors saw the final version of the manuscript. H.D. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.",

year = "2021",

month = nov,

doi = "10.2337/dc21-1181",

language = "English",

volume = "44",

pages = "e190--e191",

journal = "Diabetes Care",

issn = "0149-5992",

publisher = "American Diabetes Association",

number = "11",

}

Deshmukh, H, Wilmot, EG, Choudhary, P, Narendran, P, Shah, N, Barnes, D, Kamruddin, S, Banatwalla, R, Christian, P, Saunders, S, Lumb, A, Herring, R, Patmore, J, Walton, C, Ryder, REJ & Sathyapalan, T 2021, 'Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes: insights from the Association of British Clinical Diabetologists nationwide audit', Diabetes Care, vol. 44, no. 11, pp. e190-e191. https://doi.org/10.2337/dc21-1181

TY - JOUR

T1 - Impaired awareness of hypoglycemia and severe hypoglycemia in drivers with diabetes

T2 - insights from the Association of British Clinical Diabetologists nationwide audit

AU - Deshmukh, Harshal

AU - Wilmot, Emma G

AU - Choudhary, Pratik

AU - Narendran, Parth

AU - Shah, Najeeb

AU - Barnes, Dennis

AU - Kamruddin, Shafie

AU - Banatwalla, Rumaisa

AU - Christian, Peter

AU - Saunders, Simon

AU - Lumb, Alistair

AU - Herring, Roselle

AU - Patmore, Jane

AU - Walton, Chris

AU - Ryder, Robert E J

AU - Sathyapalan, Thozhukat

N1 - Funding Information: Acknowledgments. The authors thank all the clinicians and support staff who participated in the nationwide study, listed at https://abcd.care/ Resource/ABCD-Freestyle-Libre-Audit-Contributors. Funding. The ABCD nationwide FSL audit is supported by a grant from Abbott Laboratories. H.D. is funded by a National Institute for Health Research clinical lectureship. Duality of Interest. E.G.W. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. has received personal fees from Abbott Diabetes Care, Dex-com, Eli Lilly, Insulet, Medtronic, Novo Nordisk, and Sanofi. P.C. is also an honorary member of the Medical Advisory Panel on Diabetes to the Secretary of State for Transport. C.W. has a spouse/partner serving on the advisory panel for Celgene and on the speakers bureau for LEO Pharma and Novar-tis. R.E.J.R. serves on the advisory panel for Novo Nordisk A/S and on the speakers bureau for BioQuest. T.S. is on the speakers bureau for the Novo Nordisk Foundation and reports a relationship with Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi. The FSL audit was independently initiated and performed by ABCD, and the authors remain independent in the analysis and preparation of this report. No other potential conflicts of interest relevant to this article were reported. Author Contributions. H.D., E.G.W., C.W., R.E.J.R., and T.S. conceived the presented idea. H.D., E.G.W., C.W., R.E.J.R., and T.S. contributed to the data analysis. H.D. wrote the first draft of the manuscript. All of the authors contributed to the writing of the manuscript and made extensive comments, criticisms, and changes to the final draft of the paper. All of the authors saw the final version of the manuscript. H.D. is the guarantor of this work and, as such, had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.

PY - 2021/11

Y1 - 2021/11

UR - http://www.scopus.com/inward/record.url?scp=85120091690&partnerID=8YFLogxK

U2 - 10.2337/dc21-1181

DO - 10.2337/dc21-1181

M3 - Letter

C2 - 34526308

SN - 0149-5992

VL - 44

SP - e190-e191

JO - Diabetes Care

JF - Diabetes Care

IS - 11

ER -